background: Time-lapse monitoring (TLM) has emerged as a novel technology to perform semi-quantitative evaluation of embryo morphology and developmental kinetics in assisted reproduction. While this method has already been introduced into clinical practice in many laboratories, it is unclear whether it adds value to conventional morphology. Most studies only report blastocyst formation as the primary end-point. The aim of this systematic review is to provide a critical evaluation of the available studies that report clinical outcomes following embryo selection with TLM.
Introduction
Since the inception of clinical IVF, morphological evaluation has remained the first-line method for selecting the most developmentally competent embryo(s) from an available cohort (Edwards et al., 1981; Cummins et al., 1986) . This is despite extensive investigations of other non-invasive strategies for embryo selection, such as metabolomic profiling, along with invasive ones, such as preimplantation genetic screening. Although the discrimination function of conventional morphology is in the acceptable range of 0.7-0.8, the positive predictive value (PPV) for identifying any one viable embryo based on a threshold score is much lower, on the order of 0.3-0.4 (Racowsky et al., 2009) . Such limited predictive value has been confirmed in other studies and highlighted in recent consensus guidelines (De Placido et al., 2002; Guerif et al., 2010; Alpha, 2011) . Attention, therefore, has been focused on attempting to improve methods for morphological selection of embryos with high implantation potential.
An unresolved question is whether a single evaluation of embryo morphology shortly before transfer is adequate, or whether multiple evaluations (based on a sequential assessment of oocyte, pronuclear, cleavage stage and/or blastocyst morphology) are necessary. Several observational studies (Scott et al., 2000 (Scott et al., , 2007 Fisch et al., 2003) and randomized controlled studies (Nagy et al., 2003; Qian et al., 2008) have demonstrated a significant improvement in implantation rates following combined parameter grading. However, this multi-day approach has the limitation of requiring frequent embryo handling and several exposures to potentially embryotoxic conditions outside of the incubator.
In response, time-lapse monitoring (TLM) has emerged as a novel technology that integrates frequent image capture with undisturbed culture conditions. TLM has several potential advantages over conventional morphological grading of embryos. The technique permits the continuous evaluation of early embryo development by automated image acquisition every 5 -20 min, and accordingly does not rely on static observations to define a highly dynamic process. Furthermore, embryo scoring occurs without excursions from the incubator, so embryos are not exposed to the changes in light, humidity, temperature, pH and gas phase necessary for serial morphological grading. As such, there is less sample handling, and the risk of human error may be reduced. Some TLM systems also allow computer-assisted annotation of developmental milestones and offer a semi-quantitative process for embryo evaluation. As a result, TLM may decrease intra-and interobserver variability among embryologists (Sundvall et al., 2013) and allow de-selection of morphologically normal embryos that have a high probability of developmental arrest (Conaghan et al., 2013) . Several morphokinetic markers have been proposed as predictors of blastocyst formation (Wong et al., 2010; Cruz et al., 2012; Hashimoto et al., 2012;  reviewed by Kirkegaard et al., 2012; Chen et al., 2013; Herrero and Meseguer, 2013) . Relatively few studies, though, have assessed the utility of these markers for prediction of implantation potential.
The aim of the current systematic review is to summarize available evidence regarding the use of TLM for non-invasive selection of viable embryos.
Methods
This systematic review was prepared according to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines (Liberati et al., 2009) .
Literature search strategy
A literature search in Ovid MEDLINE, Cochrane Central Register of Controlled Trials and ISI Web of Knowledge Science Citation Index was performed to identify studies that assessed the clinical utility of kinetic markers for non-invasive selection of human embryos with high implantation potential. The search strategy was agreed upon a priori by the authors and included publications through 31 December 2013.
The following key words were used to cull the relevant literature from Ovid MEDLINE and Cochrane Central: 'time-lapse' or 'morphokinetics' or 'developmental kinetics' or 'cleavage kinetics' or 'EmbryoScope' or 'Eeva' and 'embryo' and 'implantation' or 'pregnancy.' Limits of 'human' and 'English language' were applied. The same Boolean phrase was used to search ISI Web of Science. Limits of 'Full-length article' and 'English' were applied, within the categories of Developmental Biology, Reproductive Biology, Obstetrics and Gynecology, and Medicine Research Experimental. Additional studies were identified by snowball sampling (i.e. an exhaustive review of each reference list from the relevant publications). Duplicate studies were eliminated.
Study eligibility and selection
Full-length articles were considered eligible for this systematic review if they were written in the English language and provided they evaluated the use of TLM to predict clinical outcomes. One reviewer (D.J.K.) assessed all citations for eligibility, and included studies were independently confirmed to be relevant by both authors (D.J.K. and C.R.). The excluded studies were spot-checked by the last author (C.R.) to verify accuracy of record triage. After application of the search limits listed above, the title of each publication was reviewed for relevance. Studies deemed to be irrelevant (e.g. animal models, other non-invasive methods of embryo selection such as metabolomic profiling, or TLM used in fields other than assisted reproduction) were excluded. Indeterminate titles were subjected to a secondary screen by abstract review. Studies found to be irrelevant after reviewing the abstracts were likewise excluded. The remaining articles were retrieved in full-length and assessed according to the eligibility criteria. Only studies that reported rates of implantation, clinical pregnancy or live birth were included.
Data extraction and statistics
Abstracted data included general information (title, authors, journal, year of publication), study characteristics (design, number of subjects, inclusion and exclusion criteria), cycle and laboratory parameters (patient age, method of fertilization [IVF versus ICSI] , embryo culture conditions, time interval for image acquisition, day of embryo transfer), primary and secondary endpoints (blastocyst formation, cleavage times, implantation rate, clinical pregnancy rate or live birth rate), and statistics applied. For publications that compared the mean or median times for a given morphokinetic parameter between implanted and non-implanted embryos with no implantation rates given, the corresponding author was contacted by e-mail to provide the necessary raw data to calculate the implantation rates for embryos within and outside the reported ranges. Clinical outcomes were then collated in tabular format to compare the implantation potential of embryos with normal and abnormal kinetic markers. When not published in the original citation, data were analyzed with GraphPad Software (La Jolla, CA, USA) using Fisher's exact test for categorical variables (implantation versus no implantation), and P , 0.05 was considered statistically significant. Summary measures (e.g. risk ratio or differences in means) could not be calculated for the morphokinetic parameters analyzed, given the relatively few publications meeting eligibility criteria and the heterogeneity of culture conditions, methods of fertilization and stage of embryo transfer (Day 2 through Day 6). Furthermore, any summary measure would have been subject to possible bias due to the selective reporting of parameters in several studies.
Results

Characteristics of included studies
Our literature search yielded 251 citations; 244 were identified through database search, and the remaining seven were found by reference list review. A PRISMA flow diagram illustrating the process of study screening and selection is shown in Fig. 1 . From the 251 references, 119 were excluded due to publication in a non-English language or use of animal models. Title analysis was performed and an additional 78 citations were excluded due to irrelevance. Twelve studies were excluded as they represented duplicates found elsewhere in the search. The remaining 42 articles were screened by abstract review; six were found not to be relevant. The remaining 36 articles were retrieved in full-length and assessed for inclusion. Case reports, non-comparative studies, review articles and those without clinical outcomes reported (i.e. blastocyst formation as the only end-point) were not included (n ¼ 23).
Data extraction was thus performed on 13 papers. The extracted results are summarized in Table I . Due to the heterogeneity of morphokinetic parameters tested, the inconsistency in nomenclature, and the divergent conditions used (such as culture media and volume, oxygen tension, method of fertilization, and day of embryo transfer) and, in some instances, selective reporting of results, a cumulative synthesis of data was not possible. Instead, studies were grouped together according to the type of parameter analyzed (e.g. time to a particular cell number or duration of various cleavage stages), and descriptive comparisons were performed when possible.
Measured parameters
Pronuclear dynamics and morphology
Three studies (Azzarello et al., 2012; Chamayou et al., 2013; Kirkegaard et al., 2013a) used TLM to evaluate the appearance, abuttal and syngamy, and breakdown of the male and female pronucleus (PN) as predictors of implantation. One study (Azzarello et al., 2012) reported that PN dynamics were predictive of pregnancy, while the other two (Chamayou et al., 2013; Kirkegaard et al., 2013a) detected no differences in the timing of these events between implanted and non-implanted embryos (Fig. 2) . Azzarello et al. (2012) prospectively compared the PN morphology and kinetic changes in embryos resulting in live birth (n ¼ 46) or no birth (n ¼ 113). They found that the timing of PN breakdown was significantly longer in the live birth group (24.9 + 0.6 versus 23.3 + 0.4 h; P ¼ 0.022). Moreover, when PN breakdown occurred prior to 20.8 h, no live births occurred (0/17, 0%), compared with a 32.4% live birth rate (46/142; P ¼ 0.003) when PN breakdown occurred after 20.8 h (A. Azzarello, personal communication). As such, the authors recommended not transferring embryos with PN breakdown earlier than the 20.8 h security interval. Following publication of these results, however, they observed several live births when PN breakdown occurred between 20 h and 20.8 h, but never less than 20 h (A. Azzarello, personal communication) . They reinforce that a 20 h PN breakdown time remains a reasonable lower-limit value for viable embryo selection. Of note, no PN morphologic parameters were associated with live birth; specifically, the Z-score (Scott et al., 2000) and the nucleolar precursor number, pattern and polarization were not predictive of live birth (Azzarello et al., 2012) . Chamayou et al. (2013) retrospectively compared the timing of PN appearance and breakdown between implanted (n ¼ 72) and nonimplanted (n ¼ 106) embryos, and Kirkegaard et al. (2013a) prospectively compared these time points between zygotes associated with single blastocyst transfers (n ¼ 84) resulting in clinical pregnancy or no pregnancy. Neither group reported a difference in the mean timing of these developmental milestones for blastocysts that implanted versus those that did not (Fig. 2) .
Duration of first cytokinesis and reappearance of nuclei after cleavage
Duration of the first cytokinesis was one of the original parameters reported by Wong et al. (2010) as predictive of blastocyst development. To date, only one study (Kirkegaard et al., 2013a) has correlated this with implantation: the median duration of the first cytokinesis varied between implanted embryos and non-implanted embryos (0.3 h, 95% CI 0-0.5 versus 0 h, 95% confidence interval (CI) 0-8.4, respectively; P ¼ 0.04; Fig. 2 ). However, this marker was no longer a significant predictor of pregnancy when logistic regression was applied (odds ratio (OR) 0.84, 95% CI 0.45 -1.57; P ¼ 0.59).
Time to various cleavage stages
There are three studies (Meseguer et al., 2011; Dal Canto et al., 2012; Freour et al., 2013 ;) that support a significant association between Clinical outcomes of time-lapse monitoring implantation and time to particular developmental stages during cleavage, and two studies (Chamayou et al., 2013; Kirkegaard et al., 2013a) that demonstrate no differences between cleavage kinetics.
The retrospective analysis of 247 embryos with known implantation fate by Meseguer et al. (2011) determined that times to the 2-cell, 3-cell, 4-cell and 5-cell stages were shorter among implanted embryos than non-implanted embryos. That is, fast-cleaving embryos had a higher implantation potential. After further analyses following stratification of the data into quartiles and dichotomy of embryos into the implanters versus non-implanters within the two consecutive quartiles with the highest implantation rate, the time to the 5-cell stage was identified as the kinetic parameter that most effectively discriminated between high and low implantation potential embryos. Freour et al. (2013) retrospectively analyzed development of embryos from active smokers and nonsmokers and showed that implantation rates in the first two quartiles of time to the 4-cell stage (i.e. below the median) were higher than in the last two quartiles (32.3 versus 18.1%, P , 0.05). Notably, this time point differed between smokers and non-smokers (42 versus 41 h respectively, P ¼ 0.05), but the authors did not provide the relevant data for smoking status by quartile of time to the 4-cell stage as a potential confounder.
Dal Canto et al. (2012) retrospectively compared cleavage times of embryos with known implantation fate, and found that implanted embryos (n ¼ 19) developed to the 8-cell stage faster than those that did not implant (n ¼ 115; 54.9 + 5.2 versus 58.0 + 7.2 h, P ¼ 0.035; Fig. 2 ). The times to other specific cell stages were not significantly different in the studies by Meseguer et al. (2011 ), Freour et al. (2013 ) and Dal Canto et al. (2012 (data not shown). Moreover, neither Chamayou et al. (2013) nor Kirkegaard et al. (2013a) found any significant differences in the times to development for any cell stage between implanted and nonimplanted embryos.
Duration of various cleavage stages
The association between implantation and the duration of various cell stages has been evaluated by TLM in six studies. The time-lapse parameters that seem to be associated most consistently with pregnancy are the durations of the 2-cell and 3-cell stages, as originally proposed by Wong et al. (2010) . Three studies (Meseguer et al., 2011; Rubio et al., 2012; Chen et al., 2013) reported that an untimely duration (i.e. at least one time point outside of range) of the 2-cell and/or 3-cell stage negatively affects implantation rates, while three other studies (Hlinka et al., 2012; Chamayou et al., 2013; Kirkegaard et al., 2013a) demonstrated no difference (Fig. 2) . Rubio et al. (2012) retrospectively assessed the implantation rates of embryos with 'direct cleavage' from two to three cells, defined as duration of the 2-cell stage ≤5 h. Those embryos with 'direct cleavage' had significantly lower implantation (1/85, 1.2%) than embryos with a 2-cell stage .5 h duration (203/1007, 20.2%; P , 0.0001). Chen et al. (2013) performed a secondary analysis of a prospective cohort study and compared implantation rates of embryos with timely duration (i.e. all time points within the defined ranges) of both the 2-cell and 3-cell stages. These authors report that when both parameters fell within normal ranges (2-cell: 9.33 -11.45 h and 3-cell: ≤1.73 h), pregnancy rates were higher than if only one parameter was in range (44/89, 49.4% versus 11/52, 21.2%; P ¼ 0.001). Meseguer et al. (2011) retrospectively compared the morphokinetic profiles of implanted and non-implanted embryos (n ¼ 247 embryos) and found that the mean duration of the 2-cell (11.8 + 1.2 versus 11.8 + 3.3 h; P ¼ 0.006) and 3-cell stage (0.78 + 0.73 versus 1.77 + 2.83 h, respectively; P ¼ 0.016) was significantly different between the groups. However, the times for the duration of the 2-cell stage were not normally distributed, and when the median values were compared with one another, the significance was lost. Embryos with a duration of (Campbell et al., 2013b) .
the 2-cell stage ,11.9 h (representing the first two quartiles) were more likely to implant than those with a longer duration (38/122, 31.1% versus 23/122,18.9%, respectively, P ¼ 0.022). Similarly, a ,0.76 h duration of the 3-cell stage was predictive of implantation (39/122, 32.0% versus 22/122, respectively, 18.0%; P ¼ 0.003). These authors also suggest that uneven blastomere size at the 2-cell stage, 'direct cleavage' from two to three cells, and/or multinucleation at the 4-cell stage are all parameters that should be used as exclusions for transfer due to the associated low implantation rate (4/48, 8%). Hlinka et al. (2012) retrospectively compared the implantation rates according to the chronology of divisions up to the 16-cell stage, and reported that blastocysts with timely cleavage had an implantation rate of 26.4% (28/106) while blastocysts in the untimely cleavage group (i.e. at least one time point outside of range) failed to implant (0/8). Chamayou et al. (2013) and Kirkegaard et al. (2013a) showed no differences in the durations of the 2-cell or 3-cell stages among implanted and nonimplanted embryos (Fig. 2) . Similarly, in the Kirkegaard et al. (2013a) study 'direct cleavage' to three cells (i.e. duration in the 2-cell stage of ,5 h) was not found to be predictive of pregnancy (P ¼ 0.30).
Interestingly, Lemmen et al. (2008) retrospectively compared the duration of the 2-cell and 3-cell stages in 102 embryos, and found that mode of fertilization may be an important confounder: the duration of the 2-cell stage was 2.5 h shorter following ICSI (10.5 versus 13 h, P ¼ 0.009), and the duration of the 3-cell stage was 1.3 h shorter following IVF (P . 0.05). Of note, two of the three studies that reported a significant difference between the duration of the 2-cell and 3-cell stages among implanted and non-implanted embryos Chen et al., 2013) included both IVF and ICSI cycles, while both studies that reported no difference (Hlinka et al., 2012; Kirkegaard et al., 2013a) included exclusively ICSI cycles.
Duration of cleavage cycles and mitotic synchronicity
Use of the term 'cc' for cell cycle or cleavage cycle is inconsistent throughout the literature (Table II) . Kirkegaard et al. (2013a) uses 'cc' to indicate the time required for a doubling of cell number. Thus, cc1 yields a 2-cell embryo, cc2 yields a 4-cell embryo and cc3 yields an 8-cell embryo. In contrast, other authors define 'cc' as the duration of a particular cell stage. For example, Meseguer et al. (2012) calls cc2 the duration in the 2-cell stage and cc3 the duration in the 4-cell stage, while Chamayou et al. (2013) defines cc3 as the third round of cleavage, calculated as the time to the 5-cell stage minus the time to the 3-cell stage. Of note, as defined by Kirkegaard et al. (2013a) , there were no differences in cc2 or cc3 between implanted and non-implanted embryos, respectively (cc2: 12 versus 12 h, P ¼ 0.60; cc3: 15.1 versus 15.2 h; P ¼ 0.97) but, when defined by Chamayou et al. (2013) , the median duration of cc3 was significantly longer for implanting embryos (14.4 versus 13.0 h; P ¼ 0.004). Moreover, those embryos within range of Chamayou et al.'s cc3 (9.7 -21 h) had higher implantation rates than those outside this range (72/128, 56.3% versus 0/6, 0%; P ¼ 0.009) (S. Chamayou, personal communication) .
Several studies (Hlinka et al., 2012; Chamayou et al., 2013; Freour et al., 2013; Kirkegaard et al., 2013a) assessed whether the synchronicity of mitoses within a given cleavage cycle is a predictor of pregnancy. However, again, there is inconsistency in nomenclature: in this case, the meaning of the term 'synchronicity' is variable (see Table II ). Hlinka et al. (2012) compares the implantation rates of embryos with in-range interphase and cleavage intervals from the 2-cell to 16-cell stage. Freour et al. (2013) PrimoVision is a proprietary time-lapse monitoring system that contains a video-microscope that is retro-fit into a standard incubator; annotation is performed manually. cleaving embryos were defined as those with all time periods within these limits, while untimely embryos had at least one deviation from these limits.
g Eeva System is a proprietary time-lapse monitoring system that contains a video-microscope that is retro-fit into a standard incubator and has automated cell-tracking and annotation software.
h Eeva dish is a multi-well dish that allows group embryo culture.
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Hatching was defined as the time point where projections of trophectoderm cells were visible outside the zona pellucida. Type 1 hatching was characterized by breach of the zona pellucida by trophectoderm projections with gradual emergence of the blastocyst. Type 2 hatching was characterized by a sudden rupture of the zona pellucida and a rapid emergence of the blastocyst.
j Raw values from which these percentages are derived were not reported in the original publication.
Clinical outcomes of time-lapse monitoring
Embryos with all parameters within range had similar implantation rates compared with embryos with at least one parameter outside the range (28/106, 26.4% versus 0/8, 0% respectively; P ¼ 0.2; Fig. 2) . Freour et al. (2013) reported that the duration of cleavage from the 4-cell to 8-cell stage was predictive of pregnancy (OR 2.8, 95% CI 1.2 -6.6). Among 31 implanted embryos and 160 non-implanted embryos, those with this time interval in the first two quartiles (i.e. below the median) had significantly higher implantation rates than those in the last two quartiles (32.1 versus 15% respectively, P , 0.05). However, neither Chamayou et al. (2013) nor Kirkegaard et al. (2013a) demonstrated differences in the synchrony of the third cleavage division (from the 5-cell to 8-cell stage) between implanted and non-implanted embryos (Fig. 2) .
Time to morula, blastulation, full blastocyst and hatching
Four studies compared implantation rates among cycles according to the timing of compaction and/or development of the morula or blastocyst stages (Campbell et al., 2013a; Chamayou et al., 2013; Kirkegaard et al., 2013a) . Compaction is defined as the first time point when fusion of at least two cells is observed, while morula refers to the stage at which all cells have fused. Blastulation refers to the time point at which the blastocoel cavity appears. A full blastocyst is one in which the blastocoel fills the entire embryo. Neither Kirkegaard et al. (2013a) nor Chamayou et al. (2013) observed differences between implanting and non-implanting embryos with respect to median times to either compaction or morula development (Fig. 2) . In contrast, Campbell et al. (2013a) reported that times to blastulation and full blastocyst were predictive of implantation. In a following study (Campbell et al., 2013b) , the authors retrospectively applied their previously published aneuploidy risk model to implantation by pairing morphokinetic analyses with determination of ploidy status by trophectoderm biopsy. Embryos were categorized as low, medium or high risk of aneuploidy according to times to blastulation and full blastocyst. Low aneuploidy risk embryos had blastulation ,96.2 h and full blastocyst development ,122.9 h, medium risk embryos underwent blastulation ≥96.2 h and had full blastocyst development ,122.9 h, and high risk embryos had delayed full blastocyst development ≥122.9 h (Fig. 2) . There was a stepwise decrease in implantation rates according to aneuploidy risk: low (24/33, 72.7%), medium (13/51, 25.5%) and high (0/4, 0%; P , 0.0001).
Hatching is defined as the time point where projections of the trophoectoderm breach the zona pellucida. Kirkegaard et al. (2013a) noted no differences in the median times to hatching between implanted When there was no significant difference observed between 'implanters' and 'non-implanters', only the value for the implanted embryos is shown (in black). When significant differences were reported, the 'implanter' values are shown in green, and 'non-implanters' are in red. All values are expressed in hours, as mean + standard deviation or mean (95% confidence interval) for normally distributed variables, and median (minimum:maximum) for non-normally distributed variables. PN, pronuclei. Modified from Chen et al. (2013) . and non-implanted embryos (123.1 versus 121.5 h, respectively; P ¼ 0.49; Fig. 2) . In a follow-up study by the same group, two distinct mechanisms of hatching have been described (Kirkegaard et al. (2013b) : type 1 hatching, in which the zona pellucida is breached by trophectoderm projections with gradual emergence of the blastocyst, while type 2 hatching involves a sudden rupture of the zona and a rapid emergence of the blastocyst, often directly following a blastocoel collapse. Implantation rates were similar between embryos with type 1 and type 2 hatching (19/60, 31.7% versus 9/23, 39.1%, respectively; P ¼ 0.61). Notably, type 1 hatching was more frequently associated with blastocysts from ICSI than from IVF: (210/215, 97.7% versus 92/165, 55.8%, respectively; P ¼ 0.0001), but no difference in clinical pregnancy rates was observed for the two methods of fertilization (20/58, 31% versus 28/91, 34%, respectively; P ¼ 0.72).
Hierarchal time-lapse score
There are five studies that used combined parameter grading, in which embryo selection involves an assessment of the timely or untimely development of multiple time-lapse markers to generate a cumulative score (Mesequer et al., 2011; Meseguer et al., 2012; Campbell et al., 2013a, b; Chen et al., 2013; Freour et al., 2013) . Meseguer et al. (2011) was the first to apply a sequential screen with TLM parameters in addition to conventional static grading. These investigators ranked embryos for transfer in five categories according to the following retrospective stepwise process: (i) Discard of those embryos deemed not viable by standard morphological criteria after scoring on Days 2, 3 and 5; (ii) exclusion of those embryos with uneven blastomere size at the 2-cell stage, direct cleavage to three cells (i.e. duration of the 2-cell stage ,5 h), or multinucleation at the 4-cell stage; (iii) Triage of embryos according to a strict hierarchy of in-range or out-of-range measurements for time to the 5-cell stage, duration of the 3-cell stage, and finally, duration of the 2-cell stage. This sequential screen allowed stratification of embryos by viability: the highest scoring embryos had a 66% implantation rate, while the lowest had an 8% implantation rate. Importantly, as the authors acknowledge, each of the five categories only involved 25 embryos, so one additional or one fewer implanted embryo would have changed the implantation rate by 4%. Of note, the implantation rates for embryos deemed to have the highest implantation potential by TLM were not significantly different from those ranked by conventional morphology (time-lapse: 28/54, 51.9%; conventional morphology: 15/35, 42.9%; P ¼ 0.52).
The same group published a multicenter, retrospective cohort study comparing implantation ranges between embryos selected by conventional morphology alone (n ¼ 5915 transfers) and embryos selected by this hierarchal time-lapse classification (n ¼ 1390 transfers). After adjusting for patient age, oocyte source (autologous versus donor), number of oocytes retrieved and day of transfer (Day 3 versus Day 5), embryos selected by TLM had significantly higher clinical pregnancy rates (adjusted OR 1.201, 95% CI 1.059-1.363, P ¼ 0.0043). However, it is important to recognize that the incubator systems were different between the experimental and control groups: embryos selected by TLM were cultured in the EmbryoScope (Unisense Fertilitech, Arhus, Denmark), while those selected by conventional morphology were cultured in a standard incubator. Thus, the effect of the type of incubator used and/or the undisturbed culture conditions may have confounded the relationship between improved implantation and TLM. Freour et al. (2013) offered a similar hierarchal scheme in their retrospective analysis of 135 ICSI cycles, according to the timely or untimely development to the 5-cell stage and the synchrony of the third cell cycle. Embryos with both parameters in range had an implantation rate of 38.7% while those with neither in range had an implantation rate of 15.3% (statistical significance not tested). Chen et al. (2013) and Campbell et al. (2013a) likewise provided prediction models of implantation based on several morphokinetic markers, as described above. Cleavage cycle 2 (Meseguer et al., 2011 Chamayou et al., 2013) Duration in the 3-cell stage s2 Synchronicity 2 (Meseguer et al., 2011 Chamayou et al., 2013; Kirkegaard et al., 2013a) c2 Cleavage 2 
Discussion
The principal finding of this systematic review is that there is currently limited high-quality evidence to support the routine clinical use of TLM for selection of human preimplantation embryos. The available studies that evaluate morphokinetic parameters as predictors of viability often present incomplete datasets and, when comparing them, are found to have used heterogeneous methods with, at times, conflicting results.
Of the 251 studies identified by electronic search and reference review, only 13 met the predefined eligibility criteria that specified reporting of clinical results, and only two (Azzarello et al., 2012; Campbell et al., 2013a) had live birth as an end-point. While certain parameters were associated with implantation in some studies, no single parameter was consistently found to correlate with clinical outcome. Thus, available evidence does not allow definitive conclusions regarding the utility of TLM for embryo ranking and selection. Furthermore, additional research is essential to determine which time-lapse parameter, or combination of parameters, is relevant to measure. Following validation of single or multiple parameters, evidence should be presented as to how accurately, consistently and efficiently these can be measured in the clinical setting. TLM has been shown to improve blastocyst prediction and reduce intra-and inter-observer variability (Conaghan et al., 2013; Sundvall et al., 2013) compared with conventional morphology (Arce et al., 2006; Baxter et al., 2006) . Indeed, reliable prediction of blastocyst conversion based on early morphokinetic markers may be the main advantage of TLM. The Conaghan et al. (2013) study prospectively compared the ability of a panel of three embryologists to predict blastocyst development based on conventional day 3 morphology alone versus day 3 morphology plus TLM. The addition of TLM significantly improved the specificity (52.1 versus 84.7%; P , 0.0001) and PPV (34.5 versus 54.7%; P , 0.0001) for accurate prediction of blastocyst development. Furthermore, TLM reduced inter-observer variability in both the specificity and PPV (Day 3 morphology alone: maximum differences in specificity and PPV were 37.7 and 8.9%, respectively; TLM: maximum differences in specificity and PPV were 2.5 and 4.2%, respectively).
Surprisingly few data, however, indicate whether TLM effectively distinguishes between embryos with high and low implantation potential. From this review of the 13 eligible publications, the time to various cleavage stages is the only parameter in which the weight of evidence (i.e. more than 50% of included studies) supports the utility of time-lapse for embryo selection. Of the five studies investigating this parameter, three (Meseguer et al., 2011; Dal Canto et al., 2012; Freour et al., 2013) reported that the times to the 2-cell, 3-cell, 4-cell, 5-cell and 8-cell stages were shorter among implanted embryos. In other words, faster cleaving embryos had a higher implantation potential. This observation is consistent with previously published work using conventional morphologic assessments that uniformly demonstrated that early cleavage on Day 1 and total cell number on Day 3 are predictive of implantation (Steer et al., 1992; Sakkas et al., 1998 Sakkas et al., , 2001 Lundin et al., 2001; Racowsky et al., 2003; Giorgetti et al., 2007; Chen et al., 2006) .
The majority of the 13 eligible studies that evaluated pronuclear dynamics and morphology, mitotic synchronicity, and times to morula, blastulation and hatching, suggest no association with implantation potential. The results are conflicting, and no summary statement can be provided regarding the remaining parameters assessed; these include reappearance of nuclei after cleavage, duration of cleavage stages, and duration of cleavage cycles. Those studies that integrated multiple time-lapse parameters into a cumulative scoring system for embryo selection (Mesequer et al., 2011 (Mesequer et al., , 2012 Campbell et al., 2013a, b; Chen et al., 2013; Freour et al., 2013) ultimately offered consistent prediction of clinical pregnancy. However, these models incorporated different timelapse parameters and, as such, cannot be directly compared. Finally, two of the 13 included studies compared implantation rates according to conventional morphologic grading with or without the addition of TLM (Meseguer et al., 2011; Meseguer et al., 2012) . The first paper demonstrated no significant difference in implantation rates between embryos deemed to have the highest implantation potential by TLM versus those with the best morphology by static grading, while the second reported that embryos selected by a hierarchal time-lapse classification had a relative 20.1% higher implantation rate than embryos selected by conventional morphology alone after adjusting for confounding factors (adjusted OR 1.201, 95% CI 1.059-1.363, P ¼ 0.0043). Importantly, this relative improvement was reported across 10 clinics and varied from 25% to +50% relative change, which may suggest inconsistencies in how the TLM parameters were measured or used for selection. The main criticism of this latter study is that embryos selected by TLM were cultured in the EmbryoScope, while embryos selected by conventional morphology were cultured in a standard incubator. As a result, potential confounding by differences in type of incubator and the effect of undisturbed culture were not evaluated, making it impossible to determine the true relationship between improved implantation rate and use of TLM.
The most salient limitation of this review is the possibility of reporting bias due to incomplete retrieval of relevant publications or incorrect record triage. A broad search strategy in multiple electronic databases was employed, followed by snowball sampling of reference lists in an attempt to minimize bias. We also subjected search results to a multitiered, sequential screen based on title, abstract and full-length article review; any item that was of uncertain significance at one stage was subjected to the subsequent screen to maximize sensitivity of the search. While we made every effort to ensure completeness and accuracy, these methods do not absolutely guarantee that every eligible study was retrieved from the literature and triaged appropriately.
There are several limitations associated with the studies included in this systematic review. First, no study prospectively used the measured time-lapse parameters for embryo selection, so conventional morphology still influenced which embryos were ultimately transferred. Second, due to potential confounding of undisturbed culture in the EmbryoScope , it is not possible to comment on the association between TLM parameters and improved embryo selection compared with selection using conventional morphology alone. Third, summary measures (e.g. risk ratio or differences in means) could not be calculated for each morphokinetic parameter analyzed, as relatively few publications met eligibility criteria, and the included studies had heterogeneous culture conditions (atmospheric versus 5-6% oxygen content, single-step versus sequential media, culture volume, separate versus grouped culture), mode of fertilization (IVF versus ICSI) and day of transfer (Days 2 through 6). Accordingly, these divergent methods preclude meaningful comparison among studies. Fourth, there is risk of bias due to selective reporting of parameters in several studies. For example, some studies only include a limited panel of time-lapse markers Chen et al., 2013) , while others offer a complete dataset for review (Chamayou et al., 2013; Kirkegaard et al., 2013a) . Thus, negative results may be underestimated. Fifth, several studies involve a small number of observations (e.g. implantation rates of 0/6 or 0/8), and still others do not even report raw numbers to allow the reader to understand the magnitude of the proportion. Sixth, most studies in this analysis excluded cycles with partial implantation of transferred embryos, as it was not possible to determine which embryo(s) implanted. Such exclusion of embryos with unknown fate affects both internal and external validity because results cannot be extrapolated to cycles with partial implantation. Indeed, single embryo transfer, which is the method of choice for this type of embryolevel analysis, was used in only three of the 13 studies assessed here (Lemmen et al., 2008; Hlinka et al., 2012; Kirkegaard et al., 2013a) . Finally, lack of common nomenclature also renders comparison among studies difficult (Table II) . Future studies must employ consistent, and biologically correct, terminology when describing the various milestones during early development so that TLM studies, especially those using different proprietary platforms, can be compared with one another in efforts to define more clearly the underlying biology and developmental potential of particular embryos.
Future Directions
Despite the above limitations, TLM has the potential to transform the workflow of the embryology lab due to its automated and semiquantitative process. The clinical benefit of TLM, though, has yet to be established. While the available studies indicate that certain time-lapse parameters may be predictive of implantation, more research is needed to validate these preliminary, and at times conflicting, results. Only then may it be possible to determine whether TLM outperforms conventional morphology for selection of high implantation embryos. Encouragingly, there are currently seven active clinical trials registered with the National Institutes of Health (http://clinicaltrials.gov) that aim to elucidate the role of TLM in embryo selection (Table III) . However, not all use implantation as the outcome variable. We propose that implantation of a viable fetus is the most appropriate end-point, as loss of clinical pregnancy may be confounded by uterine factor infertility or aneuploidy. As there is currently no high-quality evidence to indicate that TLM can reliably distinguish euploid from aneuploid embryos, implantation and documented development of a viable fetus to at least 8 weeks' gestation following single embryo transfer should be the criterion standard. An ideal study, yet to be performed, would measure implantation rates among patients randomized to single embryo transfer following a) embryo culture in a time-lapse system with selection based on conventional morphology alone, or b) embryo culture in a time-lapse system with selection based on morphokinetic parameters plus conventional morphology. Only such a design will allow determination of the true contribution of TLM for embryo evaluation and ranking, as the culture conditions would be held constant while the method of embryo selection varied. It is possible, for example, that undisturbed culture, and not time-lapse grading per se, may be beneficial to embryo development.
Our intent in writing this review is not to discourage further research regarding the clinical utility of TLM for embryo selection, but rather, quite the opposite: we hope to cast light on unresolved questions and inconsistencies in current nomenclature in order to motivate future appropriately designed studies. Specifically, it is critical that groups using TLM share a common nomenclature for measured time points.
To assist in standardizing TLM definitions going forward, we propose a uniform set of nomenclatures for currently identified TLM markers (Table IV) . While some of the proposed nomenclatures are already in use, we propose others for milestones that may have future utility before the 2-cell stage. We have likewise developed syntax to describe any specific developmental milestone by subtracting the time required to achieve one milestone from the time required to achieve another. Such a derived 'time interval' also allows one to determine the 'duration' spent at a specific stage (i.e. the time passed between two consecutive developmental stages).
Note that such a system requires the user to define both the start and stop times. There is currently confusion in the literature because the start time has been defined differently for standard insemination versus ICSI cycles. For ICSI oocytes, t 0 has been taken as the time of injection, that is, the time of fertilization should it occur. For standard IVF insemination, however, t 0 is undefined as the precise timing of fertilization is unknown. Thus, it has not been possible to compare precisely developmental kinetics of the two cycle types equitably. We propose the time that the first cytokinesis furrow is identified (t cf1 ) as the standard referent for all cycles because this is the first time point that is unequivocally identifiable, regardless of the fertilization method used, and, indeed, whether brightfield or darkfield illumination is used. In doing so, it will be possible to compare precisely the time intervals between embryos fertilized by IVF and those fertilized by ICSI. Use of t cf1 as the standard referent does not preclude evaluation of earlier time-lapse markers providing the start time for each is standardized (e.g. "time of ICSI" should be time of injection of each oocyte rather than the average time at which all oocytes are injected). Similarly, the start time may be chosen as a later developmental milestone; for example, the duration of the 2-cell stage is represented by t 3 -t 2 (where t 3 is time of first definitive identification of 3 cells, and t 2 is time of first definitive identification of 2 cells). We define "time of first definitive identification" as the time at which all cells for that stage are first identified as being completely separated by confluent membranes. Likewise, the time from the 8-cell stage to an expanded blastocyst is represented by t b.xd -t 8 (where t b.xd is time to expanded blastocyst and t 8 is time that all eight cells are first separated by confluent membranes).
These relationships can be represented more generally by the following formula for any time interval, t i :
where y is a more advanced developmental stage, and x is a defined referent that is always an earlier developmental stage.
Application of this proposed formula and nomenclatures permits annotation of any time point (currently identified or not), and does not rely on descriptive terms such as synchronicity, direct cleavage and cleavage cycle. This system is both standardized and inherently agile, as the syntax (t y 2 t x ) promotes a uniform method for describing any given time interval, but still allows new time-lapse markers to be defined. As such, we hope that our proposed system will facilitate the derivation of any given measure of interest along the preimplantation developmental timeline, will encourage the investigation and use of markers that are independent from one another, and enable the prospective incorporation of these parameters into models for embryo selection. Furthermore, adoption of this system should unify data generated with different imaging systems and is likely to simplify interpretation of findings obtained among future TLM studies.
Other priorities should be the creation of an international registry for safety monitoring of children born following TLM due to repeated exposure to low-intensity light and electromagnetic energy, an assessment of relative cost-effectiveness, determination of test performance (i.e. specificity, sensitivity, and number needed to treat for TLM versus conventional morphology with implantation as the end-point), correlation of time-lapse parameters with aneuploidy screening by comprehensive chromosome screening, and validation of relevant TLM markers in various patient populations and cycle types (e.g. low responders, GnRH antagonist regimens, post-thaw culture, etc.). It is unclear at this time whether clinic-specific algorithms are necessary to accommodate laboratory and patient variability, or if universal models can be applied. Demonstration that relevant TLM markers can be reliably measured and extracted in a clinical setting is critical. There is also a need for future studies to focus on time intervals that are non-overlapping and independent. Finally, whether TLM will replace static morphologic grading, or complement it, perhaps by aiding in the de-selection of morphologically similar embryos, is a matter that remains to be addressed.
Conclusions
In conclusion, there is currently insufficient high-quality evidence to support the use of TLM in routine clinical practice. Until further evidence accumulates, selection of embryos by TLM should remain an experimental strategy subject to institutional review and approval. A common nomenclature should be adopted in all future TLM studies.
